Close

Deutsche Bank Comments on Johnson & Johnson (JNJ) Q2 Results

Go back to Deutsche Bank Comments on Johnson & Johnson (JNJ) Q2 Results

Johnson & Johnson (JNJ) Tops Q2 EPS by 9c; Boosts FY13 EPS Outlook

July 16, 2013 7:49 AM EDT

(Updated - July 16, 2013 7:53 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.48, $0.09 better than the analyst estimate of $1.39. Revenue for the quarter came in at $17.88 billion versus the consensus estimate of $17.71 billion.

Our strong second-quarter results reflect the progress we've made against our near-term priorities of delivering on our financial commitments, restoring a reliable supply of over-the-counter products to... More